Objectives: Visual colour differentiation in clinical research requires colour-competent (CC) participants. The Ishihara colour charts (ICC) have established themselves as the standard for CC screening of colour vision deficiencies (CVD). However, the extent to which the results can be compared with a presentation of the colour charts on a smartphone display (SD) is currently unknown. The aim of this in vitro study was to determine the sensitivity and specificity of the Ishihara colour deficiency test depending on the presentation mode.
Methods: Dental students (female n = 28; male n = 10; mean age, 23.5 ± 2.65 years; median age, 23.0 ± 13.0 years) evaluated 25 Ishihara test plates on their SD (n = 38) and/or a calibrated monitor (HP monitor, 22-inch; n = 18). The median size of the SD was 6.0 inches. Datasets with more than 2 failed charts were scored.
Results: When the Ishihara test charts were presented on a PC screen, the sensitivity was 94.4% and the specificity was 82.4% (0 mistakes: n = 14, <3 failures: n = 3, 14 false answers: n = 1). On the SD, a sensitivity of 96.0% and a specificity of 94.7% were calculated (89.5% were correct; 4 participants [10.5%] made <3 errors; and 1 participant made 21 errors). No significant difference between display modi (PC vs SD) was evaluated (P > .05).
Conclusions: The presentation of ICC on an SD is useful and can be used for the investigation of a possible CVD of large groups. Comparable results to data projection can be achieved with a high degree of certainty. For CVD screening of larger groups (eg, students in preclinical training as part of CC training), the presentation of ICC on the SD can be used. This research was able to demonstrate that the sensitivity and specificity of the usual presentation method (Ishihara's booklet or data projection) is comparable.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287189 | PMC |
| http://dx.doi.org/10.1016/j.identj.2023.12.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Criterion validity of five open-source app-based cognitive and sensory tasks in an Australian adult life course sample aged 18 to 82: Labs without walls.
Behav Res Methods
January 2025
School of Psychology, University of New South Wales, Sydney, Australia.
With recent technical advances, many cognitive and sensory tasks have been adapted for smartphone testing. This study aimed to assess the criterion validity of a subset of self-administered, open-source app-based cognitive and sensory tasks by comparing test performance to lab-based alternatives. An in-person baseline was completed by 43 participants (aged 21 to 82) from the larger Labs without Walls project (Brady et al.
View Article and Find Full Text PDFAcquired Dyschromatopsia and Its Link to Drug Toxicity.
Cureus
December 2024
Optometric - Glaucoma, Leicester Royal Infirmary, Leicester, GBR.
Colour vision defects (CVDs) can be both congenital and acquired, with acquired dyschromatopsia often associated with medication toxicity. This review explores various standardised colour vision tests used to detect these defects, including the Ishihara plate test, Farnsworth-Munsell 100 hue test, and anomaloscopes. These methods are evaluated for their effectiveness in diagnosing CVDs, particularly in acquired conditions.
View Article and Find Full Text PDFLocal structure of amorphous sulfur in carbon-sulfur composites for all-solid-state lithium-sulfur batteries.
Commun Chem
January 2025
Graduate School of Natural Science and Technology, Shimane University, Nishikawatsu-cho, Matsue, Shimane, Japan.
All-solid-state (ASS) batteries are a promising solution to achieve carbon neutrality. ASS lithium-sulfur (Li-S) batteries stand out due to their improved safety, achieved by replacing organic solvents, which are prone to leakage and fire, with solid electrolytes. In addition, these batteries offer the benefits of higher capacity and the absence of rare metals.
View Article and Find Full Text PDFEngineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy.
J Immunother Cancer
December 2024
Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, USA
Background: The use of immune checkpoint inhibitors (CPIs) has become a dominant regimen in modern cancer therapy, however immune resistance induced by tumor-associated macrophages (TAMs) with immune suppressive and evasion properties limits responses. Therefore, the rational design of immune modulators that can control the immune suppressive properties of TAMs and polarize them, as well as dendritic cells (DCs), toward a more proinflammatory phenotype is a principal objective in cancer immunotherapy.
Methods: Here, using a protein engineering approach to enhance cytokine residence in the tumor microenvironment, we examined combined stimulation of the myeloid compartment via tumor stroma-binding granulocyte-macrophage colony-stimulating factor (GM-CSF) to enhance responses in both DCs and T cells via stroma-binding interleukin-12 (IL-12).
Dissociation of IgM antibodies from red blood cells using ethylenediamine tetraacetate/glycine acid or chloroquine diphosphate.
Transfusion
January 2025
Department of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.
Background: Ethylenediamine tetraacetate/glycine acid (EGA) and chloroquine diphosphate (CDP) are used in transfusion testing to dissociate IgG antibodies from red blood cells (RBCs). However, the ability of these reagents to dissociate IgM antibodies sensitized to RBCs has not been comprehensively elucidated. We investigated whether EGA and CDP could dissociate cold-reactive antibodies from RBCs and their effect on RBCs after dissociation treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!